Monthly Archives: May 2012

FDA challenges marketing of DMAA products for lack of safety evidence

The U.S. Food and Drug Administration has issued warning letters to at least ten manufacturers and distributors of dietary supplements containing dimethylamylamine, more popularly known as DMAA, for marketing products for which evidence of the safety of the product had not … Continue reading

Comments Off on FDA challenges marketing of DMAA products for lack of safety evidence